Nav: Home

Genetic variants linked to higher BMI may be protective against Parkinson disease

June 13, 2017

Genetic variants linked to higher body mass index (BMI) are associated with lower risk of Parkinson disease, according to a study published by Nicholas Wood and colleagues from the University College London, UK, in PLOS Medicine.

The researchers used a Mendelian randomization approach to examine whether genetic variants linked to higher BMI were also associated with risk of Parkinson disease. The associations between the genetic variants and BMI were obtained from the GIANT consortium and the relationship between the same genetic variants and Parkinson disease was ascertained from a recent meta-analysis that included 13,708 cases of Parkinson disease and 95,282 controls. The researchers observed that genetic risk expected to confer a lifetime exposure of 5-kg/m2 higher BMI was associated with an 18% lower risk of Parkinson disease (OR 0.82, 95% CI 0.69-0.98). A limitation of the approach is that individuals who have higher BMI have a higher risk of earlier mortality, and therefore individuals with lower BMI may be over-represented amongst individuals diagnosed with Parkinson disease. This "frailty effect" could at least partially account for the estimated association.

The authors say: "Although our results suggest that higher BMI is potentially protective against PD, the negative health impacts of raising BMI are likely to be significant, and should be taken into account."
-end-
Research Article

Funding:

The authors received no specific funding for this work. Other individual financial disclosures: AJN is funded by Parkinson's UK (ref F1201). DAK is supported by an MB PhD Award from the International Journal of Experimental Pathology. GH, PCH, GDS and DAL work in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_1201/1 and MC_UU_1201/5). DAL is a National Institute of Health Research Senior Investigator (NF-SI-0166-10196). PCH is supported by CRUK Population Research Postdoctoral Fellowship C52724/A20138. PAL receives funding from the MRC (MR/N026004/1 and MR/L010933/1). MN, ASi, AN and TRP participation in this study was supported in part by the Intramural Research Program of the National Institute on Aging, NIH. University College London Hospitals and University College London receive support from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres (BRC). NWW is an NIHR senior Investigator and receives support from the JPND-MRC Comprehensive Unbiased Risk factor Assessment for Genetics and Environment in Parkinson's disease (COURAGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

AJN reports: grants from Parkinson's UK, Élan/Prothena Pharmaceuticals, GE Healthcare; shares in LifeLab Ltd; advisory board membership for myHealthPal; honoraria from Office Octopus, Henry Stewart Talks, and Britannia Pharmaceuticals Ltd, all outside of the submitted work. PAL reports grants from MRC, BBSRC, National Institutes of Health, Michael J. Fox Foundation, personal fees from Astex Pharmaceuticals, outside the submitted work. TF reports grants from Michael J Fox Foundation, grants from Brain Research Trust, grants from European Union FP7, grants from John Black Charitable Foundation, personal fees from Medtronic, personal fees from BIAL, personal fees from Profile Pharma, personal fees from Brittania, all outside the submitted work. ASc reports grants from GE Healthcare, outside the submitted work. AJL reports personal fees from Britannia Pharmaceuticals Ltd, BIAL Portela, Profile Pharma Ltd, Teva, Lundbeck, Roche, UCB, NeuroDerm, Nordicinfu Care, Decision Resources, all outside of the submitted work. GDS is a member of the Editorial Board of PLOS Medicine. Mike Nalls participated in this work as a paid contractor/consultant for Kelly Government Services. DAL reports grants from UK Medical Research Council, during the conduct of the study; grants from Medical Research council, grants from Wellcome Trust, grants from European Research Council, grants from Roche Diagnostics, grants from Medtronic, grants from Ferring Pharmaceuticals, outside the submitted work. DAK, GH, ASi, AN, EDP-F, JH, NP, TRP, NWW, MN report no relevant disclosures.

Citation:

Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, et al. (2017) Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study. PLoS Med 14(6): e1002314. https://doi.org/10.1371/journal.pmed.1002314

Author Affiliations:

Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom
Centre for Neuroscience and Trauma, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom
School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America
School of Pharmacy, University of Reading, Reading, United Kingdom
Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, University College London, London, United Kingdom
Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, United Kingdom
Data Technica International, Glen Echo, Maryland, United States of America
Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, United Kingdom

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002314

PLOS

Related Genetic Variants Articles:

Rare genetic variants found to increase risk for Tourette syndrome
An international research team led by investigators at Massachusetts General Hospital and the University of California at Los Angeles -- along with their facilitating partner the Tourette Association of America -- has identified rare mutations in two genes that markedly increase the risk for Tourette syndrome (TS), a neurodevelopmental disorder characterized by chronic involuntary motor and vocal tics.
Genetic variants linked to higher BMI may be protective against Parkinson disease
Genetic variants linked to higher body mass index (BMI) are associated with lower risk of Parkinson disease, according to a study published by Nicholas Wood and colleagues from the University College London, UK, in PLOS Medicine.
Study implicates 2 genetic variants in bicuspid aortic valve development
Researchers report a key protein is affected during heart valve formation, in the first genome-wide study of bicuspid aortic valve.
Study finds new genetic variants associated with extreme old age
The search for the genetic determinants of extreme longevity has been challenging, with the prevalence of centenarians (people older than 100) just one per 5,000 population in developed nations.
Major genetic study identifies 12 new genetic variants for ovarian cancer
A genetic trawl through the DNA of almost 100,000 people, including 17,000 patients with the most common type of ovarian cancer, has identified 12 new genetic variants that increase risk of developing the disease and confirmed the association of 18 of the previously published variants.
How 1000 new genetic variants were discovered in blood groups
1000 new mutations in the blood group genes: that is what physician and former programmer Mattias Möller found in his research study in which he developed new software and investigated blood group genes in 2504 people.
Genetic variants are associated with susceptibility to mouth and throat cancer
A number of genetic variants associated with susceptibility to oral cavity and pharyngeal cancer have been described in an international study published in Nature Genetics and coordinated by the International Agency for Research on Cancer and involved 40 research groups in Europe, the United States, and South America.
WSU researchers show genetic variants and environmental exposures have influence on health
Scientists at the Wayne State University School of Medicine's Center for Molecular Medicine and Genetics have shown for the first time the extent by which interactions between environmental exposures and genetic variation across individuals have a significant impact on human traits and diseases like diabetes, heart disease and obesity, strengthening the case for precision medicine initiatives.
Rare and common genetic variants combine to cause skull-fusion disorder
Researchers have identified mutations responsible for a disorder that causes the premature fusion of the suture along the top of a baby's skull.
Genetic variants may put some soldiers at higher risk of PTSD
In a massive analysis of DNA samples from more than 13,000 US soldiers, scientists have identified two statistically significant genetic variants that may be associated with an increased risk of post-traumatic stress disorder, an often serious mental illness linked to earlier exposure to a traumatic event, such as combat and an act of violence.

Related Genetic Variants Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...